Ampersand wins £22m five-year contract at London Zoo
June 25, 2012
The Purpose Advantage: An Anchor for Sustainable Business Growth
January 5, 2025
The FINANCIAL -- On the occasion of the World Health Assembly, the world’s research-based and generic & biosimilar pharmaceutical industry bodies...
The FINANCIAL -- Bayer announced the submission of regulatory applications to the U.S. Food and Drug Administration (FDA) and the...
The FINANCIAL -- AstraZeneca’s Calquence (acalabrutinib), a next-generation selective Bruton’s tyrosine kinase (BTK) inhibitor, has been approved in the European Union...
The FINANCIAL -- AstraZeneca’s Brilinta (ticagrelor) has been approved in the US to reduce the risk of stroke, a leading cause of disability...
The FINANCIAL -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") today announced that the China National...
The FINANCIAL -- Roche today announced that new data for its approved and investigational medicines will be presented at the...
The FINANCIAL -- AstraZeneca’s Forxiga (dapagliflozin) has been approved in the European Union (EU) for the treatment of symptomatic chronic heart failure...
The FINANCIAL -- Bayer reported third quarter financial results. Highlights Group sales decrease by 5.1 percent (Fx & portfolio adj.)...
The FINANCIAL -- Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the European Commission has approved Tecentriq® (atezolizumab) in...
The FINANCIAL -- AstraZeneca has agreed to sell the commercial rights to Atacand (candesartan cilexetil) and Atacand Plus (a fixed-dose combination of candesartan cilexetil...
The FINANCIAL - Novo Nordisk published financial report for the period 1 January 2020 to 30 September 2020 Sales increased...
The FINANCIAL -- Bayer launches its first Global Creative Council. This global initiative brings together senior leaders from a variety...
The FINANCIAL -- Lilly reported Q3 financial results: - Revenue in the third quarter of 2020 increased 5 percent driven...
The FINANCIAL -- Gilead Sciences, Inc. (Nasdaq: GILD) announced the completion of the previously announced transaction to acquire Immunomedics, Inc....
The FINANCIAL -- Bayer AG today announced the acquisition of Asklepios BioPharmaceutical, Inc. (AskBio), a US-headquartered biopharmaceutical company specialized in...